Bedside Assessment of Immune Function in Patients With Covid-19
Launched by BARTS & THE LONDON NHS TRUST · Mar 14, 2025
Trial Information
Current as of May 09, 2025
Withdrawn
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over 18y age Suspected diagnosis of Covid-19 Able to give written informed consent
- Exclusion Criteria:
- • Unwilling or unable to give consent Under 18years of age Suffering from other acute septic/infective illness other than Covid-19
About Barts & The London Nhs Trust
Barts and The London NHS Trust is a leading healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality clinical care, research, and education. As a prominent sponsor of clinical trials, the Trust is dedicated to advancing medical knowledge and improving patient outcomes through innovative research initiatives. With a focus on patient safety and ethical standards, Barts and The London NHS Trust collaborates with multidisciplinary teams to explore cutting-edge therapies and interventions across various medical fields, ensuring that trial participants receive the highest level of care and support throughout their involvement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Colin Hamilton-Davies
Principal Investigator
Barts Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported